A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID.
A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID.
The fluff usually makes it a bit more approachable to the layperson though. Maybe require a link to the actual abstract as well?
I don’t want to require anything. Just makes things harder for posters and mods who have another rule to enforce.
If the link to the journal or whatever they original cite is is useful, folks will upvote the comment.